BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blasi F, Gramegna A, Sotgiu G, Saderi L, Voza A, Aliberti S, Amati F. SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity. Respir Med 2021;180:106355. [PMID: 33721697 DOI: 10.1016/j.rmed.2021.106355] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Zurlo M, Nicoli F, Proietto D, Dallan B, Zuccato C, Cosenza LC, Gasparello J, Papi C, d'Aversa E, Borgatti M, Scapoli C, Finotti A, Gambari R. Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4(+) and CD8(+) T cells. J Cell Mol Med 2023. [PMID: 36625233 DOI: 10.1111/jcmm.17655] [Reference Citation Analysis]
2 Dhama K, Nainu F, Frediansyah A, Yatoo MI, Mohapatra RK, Chakraborty S, Zhou H, Islam MR, Mamada SS, Kusuma HI, Rabaan AA, Alhumaid S, Mutair AA, Iqhrammullah M, Al-Tawfiq JA, Mohaini MA, Alsalman AJ, Tuli HS, Chakraborty C, Harapan H. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies. J Infect Public Health 2023;16:4-14. [PMID: 36446204 DOI: 10.1016/j.jiph.2022.11.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Fan Q, Nie Z, Xie S. Panorama of Breakthrough Infection Caused by SARS-CoV-2: A Review. Medicina (Kaunas) 2022;58. [PMID: 36556935 DOI: 10.3390/medicina58121733] [Reference Citation Analysis]
4 Khandia R, Singhal S, Alqahtani T, Kamal MA, El-Shall NA, Nainu F, Desingu PA, Dhama K. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res 2022;209:112816. [PMID: 35093310 DOI: 10.1016/j.envres.2022.112816] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 97.0] [Reference Citation Analysis]
5 Islam F, Dhawan M, Nafady MH, Emran TB, Mitra S, Choudhary OP, Akter A. Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions. Annals of Medicine and Surgery 2022;78:103737. [DOI: 10.1016/j.amsu.2022.103737] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
6 Sanae A, El Idrissi Adiba EB, Aicha SS. Vaccine value chain: an overview and challenges. 2022 14th International Colloquium of Logistics and Supply Chain Management (LOGISTIQUA) 2022. [DOI: 10.1109/logistiqua55056.2022.9938030] [Reference Citation Analysis]
7 Hossain MJ, Rabaan AA, Mutair AA, Alhumaid S, Emran TB, Saikumar G, Mitra S, Dhama K. Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines. Hum Vaccin Immunother 2022;:1-5. [PMID: 35172687 DOI: 10.1080/21645515.2022.2027197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zhang M, Liang Y, Yu D, Du B, Cheng W, Li L, Yu Z, Luo S, Zhang Y, Wang H, Zhang X, Zhang W. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant. Int J Biol Sci 2022;18:889-900. [PMID: 35002532 DOI: 10.7150/ijbs.68973] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
9 Portilho AI, Correa VA, Gaspar EB, De Gaspari E. Different Platforms, Immune Response Modulators and Challenges in SARS-CoV-2 Vaccination. Frontiers of COVID-19 2022. [DOI: 10.1007/978-3-031-08045-6_26] [Reference Citation Analysis]
10 Stainer A, Amati F, Suigo G, Simonetta E, Gramegna A, Voza A, Aliberti S. COVID-19 in Immunocompromised Patients: A Systematic Review. Semin Respir Crit Care Med 2021;42:839-58. [PMID: 34918325 DOI: 10.1055/s-0041-1740110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Zöllkau J, Hagenbeck C, Hecher K, Pecks U, Schlembach D, Simon A, Schlösser R, Schleußner E. [Recommendations for SARS-CoV-2/COVID-19 during Pregnancy, Birth and Childbed - Update November 2021 (Long Version)]. Z Geburtshilfe Neonatol 2021. [PMID: 34918334 DOI: 10.1055/a-1688-9398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
12 Hossain MJ, Rahman SMA, Emran TB, Mitra S, Islam MR, Dhama K. Recommendation and Roadmap of Mass Vaccination against Coronavirus Disease 2019 Pandemic in Bangladesh as a Lower-Middle-Income Country. Arch Razi Inst 2021;76:1823-30. [PMID: 35546989 DOI: 10.22092/ari.2021.356357.1824] [Reference Citation Analysis]
13 Machado BAS, Hodel KVS, Fonseca LMDS, Mascarenhas LAB, Andrade LPCDS, Rocha VPC, Soares MBP, Berglund P, Duthie MS, Reed SG, Badaró R. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines (Basel) 2021;9:1345. [PMID: 34835276 DOI: 10.3390/vaccines9111345] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Blasi F, Di Pasquale M, Gramegna A, Viale P, Iacobello C, Gori A, Tumbarello M, Esposito S, Richeldi L, Bassetti M. A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement. Respir Med 2021;190:106674. [PMID: 34788734 DOI: 10.1016/j.rmed.2021.106674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Suvvari TK, P C, Kuppili S, Kandi V, Kutikuppala LVS, Kandula VDK, Mishra S, Sarangi AK, Mohapatra RK, Dhama K. Consecutive Hits of COVID-19 in India: The Mystery of Plummeting Cases and Current Scenario. Arch Razi Inst 2021;76:1165-74. [PMID: 35355747 DOI: 10.22092/ari.2021.356147.1791] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Fenton C, Lamb YN. COVID-19: State of the Vaccination. Drugs Ther Perspect 2021;:1-11. [PMID: 34667427 DOI: 10.1007/s40267-021-00869-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Núñez-Zapata SF, Benites-Peralta B, Mayta-Tristan P, Rodríguez-Morales AJ. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity! Int J Infect Dis 2021;109:244-6. [PMID: 34260956 DOI: 10.1016/j.ijid.2021.07.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
18 Avcı H, Karabulut B, Eken HD, Faraşoğlu A, Çakil T, Çoruk S, Özel H, Kaya NK, Özbalta SÖ. Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination. Ear Nose Throat J 2021;:1455613211028493. [PMID: 34233498 DOI: 10.1177/01455613211028493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]